Amyloid-beta peptide 1-42 causes microtubule deregulation through N-methyl-D-aspartate receptors in mature hippocampal cultures

Current Alzheimer Research

Volumn 9, Issue 7, 2012, Pages 844-856

  Mota, Sandra I ^a   Ferreira, Ildete L ^a   Pereira, Cláudia ^a   Oliveira, Catarina R ^a   Rego, A Cristina ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; Amyloid beta peptide; DNA fragmentation; GluN2B subunit; Hippocampal cells; Microtubules; NMDA receptors

Indexed keywords

ALPHA TUBULIN; AMYLOID BETA PROTEIN[1-42]; BETA III TUBULIN; BETA TUBULIN; DIZOCILPINE; IFENPRODIL; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; MICROTUBULE; MICROTUBULE ASSEMBLY; NERVE CELL NECROSIS; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; CELLS, CULTURED; HIPPOCAMPUS; MICROTUBULES; N-METHYLASPARTATE; NEURONS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPSES; TUBULIN;

EID: 84866468436     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720512802455322     Document Type: Article

References (70)

1. Selkoe DJ. Toward a comprehensive theory for Alzheimer'sdisease. Hypothesis: Alzheimer's disease is caused by the cerebralaccumulation and cytotoxicity of amyloid beta-protein. Ann NYAcad Sci 924: 17-25 (2000).
2. LaFerla FM, Oddo S. Alzheimer's disease: Abeta, tau and synapticdysfunction. Trends Mol Med 11(4):170-6 (2005).
3. Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF. Multipledefects in energy metabolism in Alzheimer's disease. Curr DrugTargets 11(10): 1193-206 (2010).
4. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-betaprotein induce reversible synapse loss by modulating an NMDAtypeglutamate receptor-dependent signaling pathway. J Neurosci27(11): 2866-75 (2007).
5. Resende R, Ferreiro E, Pereira C, Resende de OC. Neurotoxiceffect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release inoligomer-induced cell death. Neuroscience 155(3): 725-37 (2008).
6. Selkoe DJ. Amyloid beta-protein and the genetics of Alzheimer'sdisease. J Biol Chem 271(31):18295-8 (1996).
7. Jan A, Adolfsson O, Allaman I, Buccarello AL, Magistretti PJ, Pfeifer A, et al. Abeta42 neurotoxicity is mediated by ongoingnucleated polymerization process rather than by discrete Abeta42species. J Biol Chem 286(10): 8585-96 (2011).
8. Chen QS, Kagan BL, Hirakura Y, Xie CW. Impairment ofhippocampal long-term potentiation by Alzheimer amyloid betapeptides. J Neurosci Res 60(1): 65-72 (2000).
9. Freir DB, Holscher C, Herron CE. Blockade of long-termpotentiation by beta-amyloid peptides in the CA1 region of the rathippocampus in vivo. J Neurophysiol 85(2): 708-13 (2001).
10. Ronicke R, Mikhaylova M, Ronicke S, Meinhardt J, Schroder UH, Fandrich M, et al. Early neuronal dysfunction by amyloid betaoligomers depends on activation of NR2B-containing NMDAreceptors. Neurobiol Aging 32(12): 2219-28 (2011).
11. Li S, Jin M, Koeglsperger T, Shepardson NE, Shankar GM, SelkoeDJ. Soluble Abeta oligomers inhibit long-term potentiation througha mechanism involving excessive activation of extrasynapticNR2B-containing NMDA receptors. J Neurosci 31(18): 6627-38(2011).
12. Henriques AG, Vieira SI, da Cruz E Silva EF, da Cruz E Silva OA. Abeta promotes Alzheimer's disease-like cytoskeletonabnormalities with consequences to APP processing in neurons. JNeurochem 113(3): 761-71 (2010).
13. Zempel H, Thies E, Mandelkow E, Mandelkow EM. Abetaoligomers cause localized Ca(2+) elevation, missorting ofendogenous Tau into dendrites, Tau phosphorylation, anddestruction of microtubules and spines. J Neurosci 30(36): 11938-50 (2010).
14. Sanz-Blasco S, Valero RA, Rodriguez-Crespo I, Villalobos C, Nunez L. Mitochondrial Ca2+ overload underlies Abeta oligomersneurotoxicity providing an unexpected mechanism ofneuroprotection by NSAIDs. PLoS One 3(7): e2718 (2008).
15. Cull-Candy SG, Leszkiewicz DN. Role of distinct NMDA receptorsubtypes at central synapses. Sci STKE 2004(255): re16 (2004).
16. Alberdi E, Sanchez-Gomez MV, Cavaliere F, Perez-Samartin A, Zugaza JL, Trullas R, et al. Amyloid beta oligomers induce Ca2+dysregulation and neuronal death through activation of ionotropicglutamate receptors. Cell Calcium 47(3): 264-72 (2010).
17. Ferreira IL, Bajouco LM, Mota SI, Auberson YP, Oliveira CR, Rego AC. Amyloid beta peptide 1-42 disturbs intracellular calciumhomeostasis through activation of GluN2B-containing N-methyl-daspartatereceptors in cortical cultures. Cell Calcium 51(2): 95-106(2012).
18. Decker H, Lo KY, Unger SM, Ferreira ST, Silverman MA. Amyloid-beta peptide oligomers disrupt axonal transport throughan NMDA receptor-dependent mechanism that is mediated byglycogen synthase kinase 3beta in primary cultured hippocampalneurons. J Neurosci 30(27): 9166-71 (2010).
19. Tackenberg C, Brandt R. Divergent pathways mediate spinealterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau. J Neurosci 29(46):14439-50 (2009).
20. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, etal. Regulation of NMDA receptor trafficking by amyloid-beta. NatNeurosci 8(8): 1051-8 (2005).
21. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ. Memantine in moderate-to-severe Alzheimer's disease. N Engl JMed 348(14):1333-41 (2003).
22. Parameshwaran K, Dhanasekaran M, Suppiramaniam V. Amyloidbeta peptides and glutamatergic synaptic dysregulation. Exp Neurol210(1): 7-13 (2008).
23. Aoki C, Lee J, Nedelescu H, Ahmed T, Ho A, Shen J. Increasedlevels of NMDA receptor NR2A subunits at pre-and postsynapticsites of the hippocampal CA1: an early response to conditionaldouble knockout of presenilin 1 and 2. J Comp Neurol 517(4): 512-23 (2009).
24. Liu J, Chang L, Roselli F, Almeida OF, Gao X, Wang X, et al. Amyloid-beta induces caspase-dependent loss of PSD-95 andsynaptophysin through NMDA receptors. J Alzheimers Dis 22(2):541-56 (2010).
25. Ambrosio AF, Silva AP, Malva JO, Mesquita JF, Carvalho AP, Carvalho CM. Role of desensitization of AMPA receptors on theneuronal viability and on the [Ca2+]i changes in cultured rathippocampal neurons. Eur J Neurosci 12(6): 2021-31 (2000).
26. Dahlgren KN, Manelli AM, Stine WB, Jr., Baker LK, Krafft GA, LaDu MJ. Oligomeric and fibrillar species of amyloid-betapeptides differentially affect neuronal viability. J Biol Chem277(35): 32046-53 (2002).
27. Joshi HC, Cleveland DW. Differential utilization of beta-tubulinisotypes in differentiating neurites. J Cell Biol 109(2): 663-73(1989).
28. Mosmann T. Rapid colorimetric assay for cellular growth andsurvival: application to proliferation and cytotoxicity assays. JImmunol Methods 65(1-2): 55-63 (1983).
29. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain andfunctional properties of four NMDA receptors. Neuron 12(3): 529-40 (1994).
30. Zhou M, Baudry M. Developmental changes in NMDAneurotoxicity reflect developmental changes in subunit compositionof NMDA receptors. J Neurosci 26(11): 2956-63 (2006).
31. Jun SB, Hynd MR, Dowell-Mesfin N, Smith KL, Turner JN, ShainW, et al. Low-density neuronal networks cultured using patternedpoly-l-lysine on microelectrode arrays. J Neurosci Methods 160(2):317-26 (2007).
32. Thomas CG, Miller AJ, Westbrook GL. Synaptic and extrasynapticNMDA receptor NR2 subunits in cultured hippocampal neurons. JNeurophysiol 95(3): 1727-34 (2006).
33. Grabrucker A, Vaida B, Bockmann J, Boeckers TM. Synaptogenesis of hippocampal neurons in primary cell culture. Cell Tissue Res 338(3): 333-41 (2009).
34. Basarsky TA, Parpura V, Haydon PG. Hippocampalsynaptogenesis in cell culture: developmental time course ofsynapse formation, calcium influx, and synaptic proteindistribution. J Neurosci 14(11 Pt 1): 6402-11 (1994).
35. Puzzo D, Privitera L, Leznik E, Fa M, Staniszewski A, Palmeri A, et al. Picomolar amyloid-beta positively modulates synapticplasticity and memory in hippocampus. J Neurosci 28(53):14537-45 (2008).
36. Tomic JL, Pensalfini A, Head E, Glabe CG. Soluble fibrillaroligomer levels are elevated in Alzheimer's disease brain andcorrelate with cognitive dysfunction. Neurobiol Dis 35(3): 352-8(2009).
37. Hashimoto M, Bogdanovic N, Volkmann I, Aoki M, Winblad B, Tjernberg LO. Analysis of microdissected human neurons by asensitive ELISA reveals a correlation between elevatedintracellular concentrations of Abeta42 and Alzheimer's diseaseneuropathology. Acta Neuropathol 119(5): 543-54 (2010).
38. Ben AS, Pascual O. Glia. the many ways to modulate synapticplasticity. Neurochem Int 57(4): 440-5 (2010).
39. Aschner M, Sonnewald U, Tan KH. Astrocyte modulation ofneurotoxic injury. Brain Pathol 12(4): 475-81 (2002).
40. Sakono M, Zako T. Amyloid oligomers: formation and toxicity ofAbeta oligomers. FEBS J 277(6): 1348-58 (2010).
41. Miguel-Hidalgo JJ, Alvarez XA, Cacabelos R, Quack G. Neuroprotection by memantine against neurodegeneration inducedby beta-amyloid(1-40). Brain Res 958(1): 210-21 (2002).
42. Klyubin I, Wang Q, Reed MN, Irving EA, Upton N, Hofmeister J, et al. Protection against Abeta-mediated rapid disruption ofsynaptic plasticity and memory by memantine. Neurobiol Aging32(4): 614-23 (2011).
43. Dinamarca MC, Colombres M, Cerpa W, Bonansco C, InestrosaNC. Beta-amyloid oligomers affect the structure and function of thepostsynaptic region: role of the Wnt signaling pathway. Neurodegener Dis 5(3-4): 149-52 (2008).
44. De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, et al. Abeta oligomers induce neuronal oxidative stressthrough an N-methyl-D-aspartate receptor-dependent mechanismthat is blocked by the Alzheimer drug memantine. J Biol Chem282(15): 11590-601 (2007).
45. Deshpande A, Kawai H, Metherate R, Glabe CG, Busciglio J. Arole for synaptic zinc in activity-dependent Abeta oligomerformation and accumulation at excitatory synapses. J Neurosci29(13): 4004-15 (2009).
46. Hu NW, Klyubin I, Anwyl R, Rowan MJ. GluN2B subunitcontainingNMDA receptor antagonists prevent Abeta-mediatedsynaptic plasticity disruption in vivo. Proc Natl Acad Sci USA106(48): 20504-9 (2009).
47. Brito-Moreira J, Paula-Lima AC, Bomfim TR, Oliveira FB, Sepulveda FJ, De Mello FG, et al. Abeta oligomers induceglutamate release from hippocampal neurons. Curr Alzheimer Res8(5): 552-62 (2011).
48. Stocca G, Vicini S. Increased contribution of NR2A subunit tosynaptic NMDA receptors in developing rat cortical neurons. JPhysiol 507 (Pt 1): 13-24 (1998).
49. Tovar KR, Westbrook GL. The incorporation of NMDA receptorswith a distinct subunit composition at nascent hippocampalsynapses in vitro. J Neurosci 19(10): 4180-8 (1999).
50. Xia P, Chen HS, Zhang D, Lipton SA. Memantine preferentiallyblocks extrasynaptic over synaptic NMDA receptor currents inhippocampal autapses. J Neurosci 30(33): 11246-50 (2010).
51. LaFerla FM. Calcium dyshomeostasis and intracellular signallingin Alzheimer's disease. Nat Rev Neurosci 3(11): 862-72 (2002).
52. Domingues A, Almeida S, da Cruz E Silva EF, Oliveira CR, RegoAC. Toxicity of beta-amyloid in HEK293 cells expressingNR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptorsubunits. Neurochem Int 50(6): 872-80 (2007).
53. Kelly BL, Ferreira A. beta-Amyloid-induced dynamin 1degradation is mediated by N-methyl-D-aspartate receptors inhippocampal neurons. J Biol Chem 281(38): 28079-89 (2006).
54. Dong H, Yuede CM, Coughlan C, Lewis B, Csernansky JG. Effectsof memantine on neuronal structure and conditioned fear in theTg2576 mouse model of Alzheimer's disease. Neuropsychopharmacology33(13): 3226-36 (2008).
55. Yang TT, Hsu CT, Kuo YM. Cell-derived soluble oligomers ofhuman amyloid-beta peptides disturb cellular homeostasis andinduce apoptosis in primary hippocampal neurons. J Neural Transm116(12):1561-9 (2009).
56. Lee MC, Ting KK, Adams S, Brew BJ, Chung R, Guillemin GJ. Characterisation of the expression of NMDA receptors in humanastrocytes. PLoS One 5(11): e14123 (2010).
57. Zhou Y, Li HL, Zhao R, Yang LT, Dong Y, Yue X, et al. Astrocytes express N-methyl-D-aspartate receptor subunits indevelopment, ischemia and post-ischemia. Neurochem Res 35(12):2124-34 (2010).
58. Butterfield DA. Amyloid beta-peptide (1-42)-induced oxidativestress and neurotoxicity: implications for neurodegeneration inAlzheimer's disease brain. A review. Free Radic Res 36(12): 1307-13 (2002).
59. Deb S, Wenjun ZJ, Gottschall PE. Beta-amyloid induces theproduction of active, matrix-degrading proteases in cultured ratastrocytes. Brain Res 970(1-2): 205-13 (2003).
60. Caumont AS, Octave JN, Hermans E. Amantadine and memantineinduce the expression of the glial cell line-derived neurotrophicfactor in C6 glioma cells. Neurosci Lett 394(3): 196-201 (2006).
61. Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, etal. Microtubule reduction in Alzheimer's disease and aging isindependent of tau filament formation. Am J Pathol 162(5):1623-7(2003).
62. Sponne I, Fifre A, Drouet B, Klein C, Koziel V, Pincon-RaymondM, et al. Apoptotic neuronal cell death induced by the non-fibrillaramyloid-beta peptide proceeds through an early reactive oxygenspecies-dependent cytoskeleton perturbation. J Biol Chem 278(5):3437-45 (2003).
63. Selkoe DJ. Soluble oligomers of the amyloid beta-protein impairsynaptic plasticity and behavior. Behav Brain Res 192(1): 106-13(2008).
64. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly fromAlzheimer's brains impair synaptic plasticity and memory. Nat Med14(8): 837-42 (2008).
65. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, et al. Abeta oligomer-induced aberrations in synapsecomposition, shape, and density provide a molecular basis for lossof connectivity in Alzheimer's disease. J Neurosci 27(4): 796-807(2007).
66. Song MS, Rauw G, Baker GB, Kar S. Memantine protects ratcortical cultured neurons against beta-amyloid-induced toxicity byattenuating tau phosphorylation. Eur J Neurosci 28(10): 1989-2002(2008).
67. Zabrecky JR, Cole RD. Effect of ATP on the kinetics ofmicrotubule assembly. J Biol Chem 257(8): 4633-8 (1982).
68. Cabado AG, Leira F, Vieytes MR, Vieites JM, Botana LM. Cytoskeletal disruption is the key factor that triggers apoptosis inokadaic acid-treated neuroblastoma cells. Arch Toxicol 78(2): 74-85 (2004).
69. Miura K, Koide N, Himeno S, Nakagawa I, Imura N. Theinvolvement of microtubular disruption in methylmercury-inducedapoptosis in neuronal and nonneuronal cell lines. Toxicol ApplPharmacol 160(3): 279-88 (1999).
70. Tsukidate K, Yamamoto K, Snyder JW, Farber JL. Microtubuleantagonists activate programmed cell death (apoptosis) in culturedrat hepatocytes. Am J Pathol 143(3): 918-25 (1993).